Form 4 for XRAY DENTSPLY SIRONA Inc.
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001127602-21-029702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-19 | 2021-11-17 | XRAY | Petersohn Walter | Chief Commercial Off | S - Sale+OE | $54.18 | -86.4K | 25.7K | -77% | -$4.68M |
| DM | 2021-11-19 | 2021-11-17 | XRAY | Petersohn Walter | Chief Commercial Off | M - OptEx | $46.25 | +41.6K | 31.2K | New | +$1.92M |
| DM | 2021-11-19 | 2021-11-17 | XRAY | Petersohn Walter | Chief Commercial Off | M - OptEx | $0.00 | -41.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-17 | S | D | 9,300 | $54.09 | 25,740.10 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2021-11-17 | S | D | 5,434 | $54.09 | 25,740.10 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2021-11-17 | S | D | 10,747 | $54.08 | 25,740.10 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2021-11-17 | M | A | 17,748 | $47.41 | 43,488.10 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-17 | S | D | 17,748 | $54.11 | 25,740.10 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 6 | Common | Common Stock | 2021-11-17 | M | A | 9,300 | $40.12 | 35,040.10 | D | — | — | |
| 7 | Common | Common Stock | 2021-11-17 | S | D | 34,068 | $54.30 | 36,487.10 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 8 | Common | Common Stock | 2021-11-17 | M | A | 9,134 | $49.29 | 34,874.10 | D | — | — | |
| 9 | Common | Common Stock | 2021-11-17 | S | D | 9,134 | $54.12 | 25,740.10 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 10 | Common | Common Stock | 2021-11-17 | M | A | 5,434 | $47.84 | 31,174.10 | D | — | — | |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-11-17 | M | D | 5,434 | $0.00 | 10,866 | D | $47.84 · — to 2030-03-04 | 5,434 Common Stock | (F10) Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023. |
| 12 | Derivative | Stock Option (Right to Buy) | 2021-11-17 | M | D | 9,134 | $0.00 | 4,566 | D | $49.29 · — to 2029-03-12 | 9,134 Common Stock | (F9) Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022. |
| 13 | Derivative | Stock Option (Right to Buy) | 2021-11-17 | M | D | 9,300 | $0.00 | 0 | D | $40.12 · — to 2028-08-09 | 9,300 Common Stock | (F8) This option is fully vested and exercisable. |
| 14 | Derivative | Stock Option (Right to Buy) | 2021-11-17 | M | D | 17,748 | $0.00 | 0 | D | $47.41 · — to 2024-11-25 | 17,748 Common Stock | (F7) This option is fully vested and exercisable. |